Abstract
The tyrosin kinase Met receptor regulates multiple cellular events, ranging from cell motility and angiogenesis to morphological differentiation and tissue regeneration. To conduce these activities, the cytoplasmic C-terminal region of this receptor acts as a docking site for multiple protein substrates, including Grb2, Gab1, STAT3, Shc, SHIP-1 and Src. These substrates are characterised by the presence of multiple domains, including the PH, PTB, SH2 and SH3 domains, which directly interact with the multisubstrate C-terminal region of Met. How this receptor recognises and binds a specific substrate in a space-temporal mode is a central question in cell signalling. The recently solved crystal structure of the tyrosine kinase domain of the Met receptor and that of domains of diverse Met substrates provides the molecular framework to understand Met substrate specificity. This structural information also gives new insights on the plasticity of Met signalling and the implications of Met deregulation in tumorigenic processes. In the light of these advances, the present work discusses the molecular basis of Met-substrate recognition and its functional implications in signalling events mediated by this pleiotropic receptor. (Mol Cell Biochem 276: 149–157, 2005)
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in~vivo. Proc Natl Acad Sci USA 90: 1937–1941, 1993
Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239–242, 1987
Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC, Hirschfield DW, Wong J, Miki T, Finch PW, Aaronson SA: A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 88: 415–419, 1991
Jeffers M, Rong S, Vande Woude GF: Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16: 1115–1125, 1996
Maina F, Hilton MC, Ponzetto C, Davies AM, Klein R: Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev 11: 3341–3350, 1997
Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C: Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373: 699–702, 1995
Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N: Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373: 702–705, 1995
Matsumoto K, Nakamura T. In: I.D. Goldberg and E.M. Rosen (eds). Hepatocyte Growth Factor-Scatter Factor and the Met Receptor, Vol. 65. Birkhaeuser Verlag, Basel, Switzerland, 1993, pp 225–250
Nusrat A, Parkos CA, Baccara AE, Godowski PJ, Delp-Archer C, Rosen EM, Madara JL: Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J Clin Invest 93: 2056–2065, 1994
Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G, Comoglio PM: A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77: 261–271, 1994
Boccaccio C, Andò M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM: Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391: 285–288, 1998
Graziani A, Gramaglia D, Cantley LC, Comoglio PM: The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J Biol Chem 266: 22087–22090, 1991
Pelicci G, Giordano S, Zhen Z, Salcini AE, Lanfrancone L, Bardelli A, Panayotou G, Waterfield MD, Ponzetto A, Pelicci PG: The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene 10: 1631–1638, 1995
Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W: Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111: 2097–2108, 1990
Biondi RM, Nebreda AR: Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem J 372: 1–13, 2003
Gu H, Neel BG: The “Gab” in signal transduction. Trends Cell Biol 13: 122–130, 2003
Liu Y, Rohrschneider LR: The gift of Gab. FEBS Lett 515: 1–7, 2002
Weidner KM, Di Cesare S, Sachs M, Brinkmann V, Behrens J, Birchmeier W: Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384: 173–176, 1996
Dean M, Park M, Vande Woude GF: Characterization of the rearranged Tpr-Met oncogene breakpoint. Mol Cell Biol 7: 921–924, 1987
Itoh M, Yoshida Y, Nishida K, Narimatsu M, Hibi M, Hirano T: Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol Cell Biol 10: 3695–3704, 2000
Lock LS, Royal I, Naujokas MA, Park M: Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J Biol Chem 275: 31536–31545, 2000
Schaeper U, Gehring NH, Fuchs KP, Sachs M, Kempkes BBW: Coupling of Gab1 to c-Met, Grb2 and downstream effectors mediates biological responses. J Cell Biol 149: 1419–1432, 2000
Holgado-Madruga M, Moscatello DK, Emlet DR, Dieterich R, Wong AJ: Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc Natl Acad Sci USA 94: 12419–12424, 1997
Kameda H, Risinger JI, Han BB, Baek SJ, Barrett JC, Abe T, Takeuchi T, Glasgow WC, Eling TE: Expression of Gab1 lacking the pleckstrin homology domain is associated with neoplastic progression. Mol Cell Biol 21: 6895–6905, 2001
Schlessinger J, Lemmon MA: SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 191: RE12, 1–12, 2003
Maroun CR, Naujokas MA, Holgado-Madruga M, Wong AJ, Park M: The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 20: 8513–8525, 2000
Sachs M, Brohmann H, Zechner D, Muller T, Hulsken J, Walther I, Schaeper U, Birchmeier C, Birchmeier W: Essential role of Gab1 for signaling by the c-Met receptor in~vivo. J Cell Biol 150: 1375–1384, 2000
Osawa M, Itoh S, Ohta S, Huang Q, Berk BC, Marmarosh NL, Che W, Ding B, Yan C, Abe J: ERK1/2 associates with the c-Met-binding domain of growth factor receptor-bound protein 2 (Grb2)-associated binder-1 (Gab1): Role in ERK1/2 and early growth response factor-1 (Egr-1) nuclear accumulation. J Biol Chem 279: 29691–29699, 2004
Rocchi S, Tartare-Deckert S, Murdaca J, Holgado-Madruga M, Wong AJ, Van Obberghen E: Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules. Mol Endocrinol 12: 914–923, 1998
Roshan B, Kjelsberg C, Spokes K, Eldred A, Crovello CS, Cantley LG: Activated ERK2 interacts with and phosphorylates the docking protein GAB1. J Biol Chem 274: 36362–36368, 1999
Terasawa H, Kohda D, Hatanaka H, Tsuchiya S, Ogura K, Nagata K, Ishii S, Mandiyan VAU, Schlessinger J: Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos. Nat Struct Biol 1: 889–891, 1994
Goudreau N, Cornille F, Duchesne M, Parker F, Tocque B, Garbay C, Roques B: NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos. Nat Struct Biol 1: 898–907, 1994
Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B, Schlessinger J: Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363: 85–88, 1993
Nguyen L, Holgado-Madruga M, Maroun C, Fixman E, Kamikura D, Fournier T, Charest A, Tremblay M, Wong A, Park M: Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356. J Biol Chem 272: 20811–20819, 1997
Fixman E, Holgado-Madruga M, Nguyen L, Kamikura D, Fournier T, Wong A, Park M: Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1. J Biol Chem 272: 20167–20172, 1997
Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ: Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379: 560–564, 1996
Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D: The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363: 83–85, 1993
Fixman ED, Fournier TM, Kamikura DM, Naujokas MA, Park M: Pathways downstream of Shc and Grb2 are required for cell transformation by the Tpr-Met oncoprotein. J Biol Chem 271: 13116–13122, 1996
Luzi L, Confalonieri S, Di Fiore PP, Pelicci PG. Evolution of Shc functions from nematode to human. Curr Opin Genet Dev 10: 668–674, 2000
Ravichandran KS: Signaling via Shc family adapter proteins. Oncogene 20: 6322–6330, 2001
Trub T, Choi WE, Wolf G, Ottinger E, Chen Y, Weiss M, Shoelson SE: Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J Biol Chem 270: 18205–18208, 1995
Uhlik MT, Temple B, Bencharit S, Kimple AJ, Siderovski DP, Johnson GL: Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J Mol Biol 345: 1–20, 2005
Resh MD: Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76: 411–413, 1994
Pawson T, Gish GD: SH2 and SH3 domains: from structure to function. Cell 71: 359–362, 1992
Bromann PA, Korkaya H, Courtneidge SA: The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23: 7957–7968, 2004
Shupnik MA: Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene 23: 7979–7989, 2004
Mayer BJ: SH3 domains: complexity in moderation. J Cell Sci 114: 1253–1263, 2001
Smart JE, Oppermann H, Czernilofsky AP, Purchio AF, Erikson RL, Bishop JM: Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). Proc Natl Acad Sci USA 78: 6013–6017, 1981
Ely CM, Tomiak WM, Allen CM, Thomas L, Thomas G, Parsons SJ: pp60c-src enhances the acetylcholine receptor-dependent catecholamine release in vaccinia virus-infected bovine adrenal chromaffin cells. J Neurochem 62: 923–933, 1994
Wada T, Sasaoka T, Ishii M, Hori H, Haruta T, Ishihara H, Kobayashi M: Role of the Src Homology 2 (SH2) Domain and C-Terminus Tyrosine Phosphorylation Sites of SH2-Containing Inositol Phosphatase (SHIP) in the Regulation of Insulin-Induced Mitogenesis. Endocrinology 140: 4585–4594, 1999
Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold A, Rohrschneider LR: p150Ship, a signal transduction molecule with inositol polyphosphate-5- phosphatase activity. Genes Dev 10: 1084–1095, 1996
Harder KW, Quilici C, Naik E, Inglese M, Kountouri N, Turner A, Zlatic K, Tarlinton DM, Hibbs ML: Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHIP-1 and SHIP-1. Blood 104: 3901–3910, 2004
Machide M, Kamitori K, Kohsaka S: Hepatocyte growth factor-induced differential activation of phospholipase cgamma 1 and phosphatidylinositol 3-kinase is regulated by tyrosine phosphatase SHP-1 in astrocytes. J Biol Chem 275: 31392–31398, 2000
Royal I, Fournier TM, Park M: Differential requirement of Grb2 and PI3K in HGF/SF-induced cell motility and tubulogenesis. J Cell Physiol 173: 196–201, 1997
Yu Z, Su L, Hoglinger O, Jaramillo ML, Banville D, Shen S-H: SHIP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 273: 3687–3694, 1998
Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM: Structure, function, and biology of SHIP proteins. Genes Dev 14: 505–520, 2000
Kodama A, Matozaki T, Shinohara M, Fukuhara A, Tachibana K, Ichihashi M, Nakanishi H, Takai Y: Regulation of Ras and Rho small G proteins by SHP-2. Genes Cells 6: 869–876, 2001
Kameda H, Risinger JI, Han BB, Baek SJ, Barrett JC, Glasgow WC, Eling TE: Identification of epidermal growth factor receptor-Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression. Cell Growth Differ 12: 307–318, 2001
Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, Testa JR: Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA 98: 247–252, 2001
Abounader R, Ranganathan S, Kim BY, Nichols C, Laterra J: Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. J Neurochem 76: 1497–1508, 2001
Becker S, Groner B, Muller CW: Three-dimensional structure of the Stat3-homodimer bound to DNA. Nature 394: 145–151, 1998
Wen Z, Zhong Z, Darnell JE, Jr: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241–250, 1995
Bromberg J, Darnell JE, Jr: The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19: 2468–2473, 2000
Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE, Kuriyan J: Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93: 827–839, 1998
Sasse J, Hemmann U, Schwartz C, Schniertshauer U, Heesel B, Landgraf C, Schneider-Mergener J, Heinrich PC, Horn F: Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol Cell Biol 17: 4677–4686, 1997
Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy DJ: Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in~vitro. J Clin Investig 102: 1385–1392, 1998
Klosek SK, Nakashiro K, Hara S, Li C, Shintani S, Hamakawa H: Constitutive activation of Stat3 correlates with increased expression of the c-Met/HGF receptor in oral squamous cell carcinoma. Oncol Rep 12: 293–296, 2004
Yuan ZL, Guan YJ, Wang L, Wei W, Kane AB, Chin YE: Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol Cell Biol 24: 9390–9400, 2004
Schiering N, Knapp S, Marconi M, Flocco MM, Cui J, Perego R, Rusconi L, Cristiani C: Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a. Proc Natl Acad Sci USA 100: 12654–12659, 2003
Hunter T, Cooper JA: Protein-tyrosine kinases. Annu Rev Biochem 54: 897–930, 1985
Bolanos-Garcia, VM: Aurora kinases. Int J Biochem Cell Biol (in press): 2005
Berthou S, Aebersold DM, Schmidt LS, Stroka D, Heigl C, Streit B, Stalder D, Gruber G, Liang C, Howlett AR, Candinas D, Greiner RH, Lipson KE, Zimmer Y: The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants. Oncogene 23: 5387–5393, 2004
Lee CC, Yamada KM: Identification of a novel type of alternative splicing of a tyrosine kinase receptor. Juxtamembrane deletion of the c-met protein kinase C serine phosphorylation regulatory site. J Biol Chem 269: 19457–19461, 1994
Lee CC, Yamada KM: Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. Deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-OH kinase to the hepatocyte growth factor receptor. J Biol Chem 270: 507–510, 1995
Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, et~al: SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767–778, 1993
Schiering N, Casale E, Caccia P, Giordano P, Battistini C: Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex. Biochemistry 39: 13376–13382, 2000
Bardelli A, Comoglio PM: Scatter factor receptors are key players in a unique multistep program leading to invasive growth. Ciba Found Symp 212: 133–147, 1997
Lock LS, Frigault MM, Saucier C, Park M: Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain. J Biol Chem 278: 30083–30090, 2003
Schaaf CP, Benzing J, Schmitt T, Erz DH, Tewes M, Bartram CR, Janssen JW: Novel interaction partners of the TPR/MET tyrosine kinase. FASEB J 19: 267–269, 2005
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bolanos-Garcia, V.M. MET meet adaptors: Functional and structural implications in downstream signalling mediated by the Met receptor. Mol Cell Biochem 276, 149–157 (2005). https://doi.org/10.1007/PL00022009
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/PL00022009